Literature DB >> 12169206

MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis.

K Demopoulos1, D A Arvanitis, D A Vassilakis, N M Siafakas, D A Spandidos.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic interstitial pneumonia limited to the lung and characterized by a fibroproliferative response with only minor signs of inflammation, which almost always causes rapid fibrotic destruction of the lung. In this study, we investigated genomic instability in IPF, using microsatellite DNA analysis, aiming to detect any specific genetic alterations for this disease. We used 40 highly polymorphic microsatellite DNA markers, in multiplex PCR assays, to examine 52 sputum specimens from IPF patients versus correspondent venous blood. Loss of heterozygosity (LOH) was found in 20 (38.5%) patients in at least one locus. These alterations were found on markers previously associated with lung cancer located on 1p34.3, 3p21.32-p21.1, 5q32-q33.1, 9p21 and 17p13.1 where MYCL1, FHIT, SPARC, p16(Ink4) and TP53 genes have been mapped respectively. These data provide new insights into IPF pathogenesis and a new perspective for its correlation with lung cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169206      PMCID: PMC6740283          DOI: 10.1111/j.1582-4934.2002.tb00188.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  22 in total

1.  SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Authors:  Sabina Sangaletti; Claudio Tripodo; Barbara Cappetti; Patrizia Casalini; Claudia Chiodoni; Silvia Piconese; Alessandra Santangelo; Mariella Parenza; Ivano Arioli; Silvia Miotti; Mario P Colombo
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

2.  Genomic rearrangements on VCAM1, SELE, APEG1and AIF1 loci in atherosclerosis.

Authors:  D A Arvanitis; G A Flouris; D A Spandidos
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 3.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 4.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 5.  MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Authors:  Keiko Mizuno; Hiroko Mataki; Naohiko Seki; Tomohiro Kumamoto; Kazuto Kamikawaji; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

Review 6.  Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Authors:  Argyris Tzouvelekis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2006-05-25

7.  Tonsillar metastasis of small cell lung cancer in a patient with idiopathic pulmonary fibrosis: a case report.

Authors:  Eo Jin Kim; So Ri Kim; Su Jin Gang; Seung Yong Park; Young Min Han; Yong Chul Lee
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

8.  Idiopathic pulmonary fibrosis and cancer: do they really look similar?

Authors:  Carlo Vancheri
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

9.  Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility.

Authors:  Indra Adrianto; Chee Paul Lin; Jessica J Hale; Albert M Levin; Indrani Datta; Ryan Parker; Adam Adler; Jennifer A Kelly; Kenneth M Kaufman; Christopher J Lessard; Kathy L Moser; Robert P Kimberly; John B Harley; Michael C Iannuzzi; Benjamin A Rybicki; Courtney G Montgomery
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  Aberrant methylation of SPARC in human lung cancers.

Authors:  M Suzuki; C Hao; T Takahashi; H Shigematsu; N Shivapurkar; U G Sathyanarayana; T Iizasa; T Fujisawa; K Hiroshima; A F Gazdar
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.